The merger is complete and the issuer will deregister. No further trading or activist engagement is possible; the stock will be delisted from the OTC Pink Market.
Price Chart
Executive Summary
TB Alternative Assets Ltd. and other reporting persons filed this final amendment to Schedule 13D to report that, following the October 28, 2026 merger of Cloopen Group Holding Ltd with a merger subsidiary, the reporting persons no longer beneficially own any ordinary shares or ADSs of the issuer. The merger was approved by approximately 99.98% of votes cast at a September 24, 2026 extraordinary general meeting, and shareholders received US$0.4940 per ordinary share or US$2.9641 per ADS in cash.
Key Financial Metrics
Key Facts
- Merger became effective on October 28, 2026.
- Shareholders received US$0.4940 per ordinary share and US$2.9641 per ADS in cash.
- Merger was approved by approximately 99.98% of votes cast at the EGM.
- Reporting persons now hold zero beneficial ownership in the issuer.
- This is the final amendment to the Schedule 13D; the issuer will become a privately-held company and intends to file Form 15 to suspend reporting obligations.
Financial Impact
Merger consideration of US$0.4940 per ordinary share and US$2.9641 per ADS in cash; all outstanding shares and ADSs cancelled.
Risk Factors
- No further equity trading or activist activity possible; stock will be delisted.
- Dissenting shareholders may seek fair value appraisal under Cayman Islands law.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001193125-26-436889 |
| Document: 0001193125-26-436889-index.html | 0001193125-26-436889 |
| Document: 0001193125-26-436889.txt | 0001193125-26-436889 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 3d ago | 15-12G | $2.86 | awaiting T+60 | awaiting T+60 | $2.85 (−0.35%) |
Oct 29, 2026 3d ago | SC 13E-3/A | $2.86 | awaiting T+60 | awaiting T+60 | $2.85 (−0.35%) |
Oct 29, 2026 3d ago | SC 13D/A | $2.86 | awaiting T+60 | awaiting T+60 | $2.85 (−0.35%) |
Oct 28, 2026 4d ago | 6-K | $2.86 | awaiting T+60 | awaiting T+60 | $2.85 (−0.35%) |
Sep 24, 2026 5w ago | 6-K | $2.58 | awaiting T+60 | awaiting T+60 | $2.85 (+10.47%) |
May 12, 2026 24w ago | 6-K | $2.35 $2.08 | ▼ −11.49% | ▼ −15.87% | $2.85 (+21.28%) |
May 8, 2026 25w ago | 6-K | $1.41 $2.07 | ▲ +46.81% | ▲ +42.42% | $2.85 (+102.13%) |
May 8, 2026 25w ago | 20-F | $1.35 $2.07 | ▼ −53.33% | ▼ −48.49% | $2.85 (−111.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers